Top Companies in Protein Expression Market

The protein expression market is projected to reach USD 7.65 billion by 2031, up from USD 5.14 billion in 2026, at a CAGR of 8.3%. The growth of the protein expression market is driven by the expanding global biologics and biosimilar pipeline and rising government and venture-capital R&D funding. Additionally, emerging algal expression systems and the broader adoption of platforms such as cell-free and plant-based expression systems are expected to support market growth.

The global protein expression market is consolidated, with top players such as Thermo Fisher Scientific (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), and Agilent Technologies (US) leading the market. The market players have adopted various strategies, including approvals and launches of new products and services, acquisitions, agreements, collaborations, partnerships, and geographic expansions, to strengthen their positions in the global protein expression market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific is a leading participant in the protein expression market, offering a comprehensive portfolio of protein expression systems, cell culture media, expression vectors, competent cells, reagents, purification solutions, and analytical instruments. The company supports pharmaceutical, biotechnology, and academic organizations across recombinant protein development, process optimization, and commercial-scale biologics manufacturing through its global infrastructure, integrated workflow solutions, and continuous investments in bioprocessing and life science technologies.

Merck KGaA (Germany)

Merck KGaA is a prominent player in the protein expression market, providing a broad range of cell culture technologies, expression platforms, media formulations, process chemicals, filtration systems, and bioprocess solutions. Through its life science portfolio, the company enables efficient protein production and scale-up activities for biopharmaceutical manufacturers, supported by advanced manufacturing capabilities and strategic investments in next-generation biologics technologies.  

Danaher Corporation (US)

Danaher is a key participant in the protein expression market through its life sciences subsidiaries and bioprocessing businesses, delivering solutions including expression systems, cell culture tools, bioprocess technologies, chromatography products, and analytical platforms. The company supports protein research and biotherapeutic production workflows from discovery through manufacturing with integrated technologies and continued expansion in biologics and genomic sciences.  

Agilent Technologies (US)

Agilent Technologies is a major player in the protein expression market, providing analytical instruments, cell analysis technologies, automation systems, and quality control solutions for protein characterization and expression workflow optimization. The company supports researchers and biopharmaceutical manufacturers through advanced analytical capabilities, helping improve productivity, reproducibility, and process efficiency in protein development programs.

Market Ranking

The protein expression market is characterized by moderate to high consolidation, with leading players controlling a share of global revenues estimated at around 50% to 55% of the total market.  These major companies strengthen their market positions through strategic acquisitions, expansion of bioprocessing capabilities, technological innovation, and broad product portfolios spanning instruments, reagents, expression systems, and services.

Thermo Fisher Scientific (US) offers a comprehensive protein expression portfolio, including mammalian, microbial, insect, and cell-free expression systems, along with media, vectors, cell lines, and purification technologies supporting research and biomanufacturing workflows. Merck KGaA (Germany) provides integrated solutions for protein expression and bioprocessing through its life science portfolio, offering expression platforms, cell culture media, process development tools, and downstream purification technologies for biologics manufacturing.

Danaher Corporation (US), through subsidiaries including Cytiva and Pall, delivers end-to-end protein production solutions encompassing cell culture technologies, expression systems, bioprocess hardware, and scalable manufacturing platforms for therapeutic protein development. Sartorius AG (Germany) focuses on advanced bioprocess and protein production technologies, including cell cultivation systems, bioreactors, media optimization tools, and integrated process solutions designed to improve productivity and manufacturing efficiency.

The remainder of the market, accounting for approximately 45–50%, consists of regional suppliers and niche technology developers. These players are expanding through targeted innovation, localized collaborations, and customized protein expression solutions tailored to academic institutions, emerging biotechnology companies, contract research organizations (CROs), and small-scale biomanufacturers requiring flexible and application-specific production capabilities

Related Reports:

Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]